Helus Pharma

HELPNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$786.144 M

$10.76 -5.78%

Close of 7 Oct 2026

As of 7 Oct 2026, Helus Pharma (HELP) has a market capitalization of $786.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#165Immix BiopharmaIMMX$799.2M
#166Gyre TherapeuticsGYRE$789.5M
#167Helus PharmaHELP$786.1M
#168Lexicon PharmaceuticalsLXRX$778.7M
#169GeronGERN$777.4M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Helus Pharma, worth $1.35M. Grants and option exercises are excluded.

Michael HalsteadChief Executive Officer$1.35M
100,000 shares at $13.47 on 21 Sept 2026 · filed 21 Sept 2026

What if Helus Pharma were worth as much as…

Open the what-if tool →

Gold $28.8T

$394,042.84

Per share 36,621× higher

Bitcoin $1.67T

$22,860.79

Per share 2,125× higher

Nvidia $5.77T

$78,915.29

Per share 7,334× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Helus Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.